Search Cosmetics & Toiletries

93 Results

Section: Research

Eighteen studies identified complications such as rash, irritation, immune system disorders, stratum corneum DNA damage and hormonal disruption.

Literature Review Connects Sunscreen Absorption with Potential Adverse Effects

A literature review published in Dermatology Research suggests the potential adverse effects, i.e., irritation, rashes, hormone disruption, etc., of sunscreen ingredients absorbed into human skin and present in human plasma and urine.

US FDA Pushes Sunscreen Reform on Three Fronts

The U.S. Food and Drug Administration has announced three new efforts to advance its framework for sun protection products including Maximal Usage Trials (MUsT)—just ahead of summer vacation and in line with #DontFryDay.

FrustratedResearcherWomanLaptop850x425

Why the FDA's 'Sunscreens in the Bloodstream' Study is Flawed

A recent study published in the Journal of the American Medical Association tested the potential systemic absorption of certain sunscreens. Results identified their presence in subjects' bloodstreams; however, as industry expert David Steinberg explains, the study is misleading and fails to consider crucial variables.

CT.com_RecedingHair

FDA Approves Hair Growth Laser

The US Food and Drug Administration (FDA) has approved a hand-held, at-home device that claims to regrow hair for men and women.

FDA Warns Skin Treatment Devices

The US Food and Drug Administration (FDA) has warned the manufacturers of devices that it will regulate some differently than cosmetics.

FDA DODAC Approves Eyelash Drug

Allergan Inc. has announced that the U.S. Food and Drug Administration DODAC voted unanimously to recommend that the FDA approve Latisse.

Prescription Polymer Nail Treatment Approved by the FDA

The U.S. Food and Drug Administration (FDA) has approved a prescription polymer treatment for brittle nail symdrome (nail dystrophy).

Olumiant is a Janus kinase (JAK) inhibitor, which blocks the activity of one or more of a specific family of enzymes, interfering with the pathway that leads to inflammation, thereby, treating patients with alopecia areata.

FDA Approves First Systemic Alopecia Areata Treatment

Olumiant is a Janus kinase (JAK) inhibitor, which blocks the activity of one or more of a specific family of enzymes, interfering with the pathway that leads to inflammation to thereby treat patients with alopecia areata.

FDA Clears Isoprenylcysteine Analog for Rosacea Treatment

A isoprenylcysteine (IPC) analog manufactured by biopharmaceutical company Signum Dermalogix Inc. (Dermalogix) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of rosacea.

MarijuanaCosmeticMortarPestle850x425

FDA Clears the Air on CBD Reform Efforts

While CBD is trending across market segments, the rules in play to ensure public health and market direction are baffling at best. As such, the FDA has issued an update outlining its efforts to provide clarity.

BiologyCells850

FDA Sets Regulatory Framework for Regenerative Biological Therapies

It's a sign of the times when technology and innovation hit a point where the U.S. Food and Drug Administration must stop and write new rules to ensure consumer safety. That time, with respect to regenerative biological therapies, is now.

PowderMakeupEyeShadowBrushes_850x425

[update] Asbestos in Talc? Latest FDA Tests Find No Evidence

Asbestos fibers were not detected in any of the 50 samples tested via PLM or TEM. While this is good news, one expert highlights how the report demonstrates the FDA's fundamental lack of understanding of chemistry and formulations.

While the overall trend for color cosmetics has been positive, a return to pre-pandemic levels appears to be progressing slowly.

Lipstick Forecasts Not So Rosy, FDA Color Additives Report Reveals

Many trend agencies and news outlets are reporting an increase in lipstick sales for 2022 but those numbers may not paint the full picture. Here's what the latest FDA Color Additives report reveals, as outlined by industry expert Kelly Dobos.

News-Insights-12-6-19_850x425

[video] FDA Warnings on CBD; Hair Softness; and User-induced Product Contamination

Back from break, here's Cosmetics & Toiletries' Rachel Grabenhofer, with her top headline picks in cosmetics R&D news. Watch now!

WomanResearcherMicrobePetriDishes850

Is Your Microbiology Lab FDA-compliant? Part II: Cultures, Growth Media, Reagents and Testing

This two-part article provides an overview of areas relevant to the U.S. Food and Drug Administration’s (FDA’s) inspection of cosmetic microbiology laboratories. Part 1 covered personnel, facilities and equipment, test materials and procedures, and documentation. Part 2 addresses microbial cultures and growth media, biochemical reagents, test procedures and more.

WomanRejoiceSunBeachbag850x425

Photostability Leads the Way: Formulating Safer Sunscreens

The need to prevent skin from UV damage is well-understood but the most effective way to achieve this is not. Here, a novel photostabilizer is presented in a test pump sunscreen spray formula as part of a total photoprotection strategy.

Sunscreen Across the Spectrum?

Newer to the scene are products that protect skin against infrared radiation, as well as research on the effects of high energy visible and visible light. In response, at the C&T Summit, Jürgen Lademann, PhD, will present "Should Sunscreens Protect Across the Whole Solar Spectrum?"

Patent Picks—Reactivating Sunscreens; Etched UV Protection; Jaboticaba/Cashew Skin Care; Water-soluble Sunscreens

Patent Picks are taken from publicly available sources and cover recent patents issued or applied for in the cosmetic and personal care industries and relevant peripheral markets. This edition features sun protection and skin repair technologies.

Page 1 of 6